Cardiovascular Therapeutics·3 OctAtorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk ManagementReviewAtorvastatinPaper
BME Frontiers·23 SepBilateral Angular Gyrus 810-nm Transcranial Near-Infrared Stimulation Reshapes Brain Network: Ameliorate Alzheimer's Disease Cognitive DeficitsTrial in peopleInterventionsPaper
Journal of Alzheimer's Disease·3 SepComparison of baseline characteristics between cognitively normal and mild cognitive impairment and association of white matter hyperintensity trajectories with diagnostic outcomes, cognition, and amyloid-β protein: A longitudinal studyCohort study of 857 peopleMild cognitive impairmentPaper
AAIC 2025 Abstract·26 DecCharacteristics of patients on Lecanemab treatment at West China Hospital of Sichuan University: perspectives from real‐world experience.Study in peopleInterventionsPaper
AAIC 2025 Abstract·24 DecA Multimodal Fusion Framework for Early Detection of Cognitive Impairment in Chinese Speakers Using Pinyin Sequences and Acoustic FeaturesComputational studyBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunPost Hoc Analysis of Efsubaglutide Alfa Monotherapy and Combined Therapy with Metformin in T2D Patients by Baseline CharacteristicsTrial in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunA Novel Antibody–Peptide Conjugate Targeting PCSK9,GLP-1R,GCGR,GIPR Improves Cardiovascular Risk Markers in Preclinical StudyExperiments in animalsInterventionsPaper